SE438150B - 4,5,6,7-tetrahydroimidazo(4,5-c)pyridinderivat och forfarande for deras framstellning - Google Patents
4,5,6,7-tetrahydroimidazo(4,5-c)pyridinderivat och forfarande for deras framstellningInfo
- Publication number
- SE438150B SE438150B SE7811761A SE7811761A SE438150B SE 438150 B SE438150 B SE 438150B SE 7811761 A SE7811761 A SE 7811761A SE 7811761 A SE7811761 A SE 7811761A SE 438150 B SE438150 B SE 438150B
- Authority
- SE
- Sweden
- Prior art keywords
- tetrahydroimidazo
- formula
- pyridine
- carbon atoms
- alkyl
- Prior art date
Links
- URMVFILWXLQJIP-UHFFFAOYSA-N 4,5,6,7-tetrahydro-3h-imidazo[4,5-c]pyridine Chemical class C1NCCC2=C1NC=N2 URMVFILWXLQJIP-UHFFFAOYSA-N 0.000 title claims description 9
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 claims description 3
- PMNTUQDILMRXPB-UHFFFAOYSA-N 1-methyl-n-propan-2-yl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound C1N(C(=S)NC(C)C)CCC2=C1N=CN2C PMNTUQDILMRXPB-UHFFFAOYSA-N 0.000 claims description 2
- JPAQUOZTKDYTRV-UHFFFAOYSA-N 4-ethyl-1-methyl-n-propan-2-yl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound CCC1N(C(=S)NC(C)C)CCC2=C1N=CN2C JPAQUOZTKDYTRV-UHFFFAOYSA-N 0.000 claims description 2
- 239000002168 alkylating agent Substances 0.000 claims description 2
- 229940100198 alkylating agent Drugs 0.000 claims description 2
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 230000007704 transition Effects 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- QUXKHZNZCYIGGS-UHFFFAOYSA-N 1,4-diethyl-n-propan-2-yl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound CCC1N(C(=S)NC(C)C)CCC2=C1N=CN2CC QUXKHZNZCYIGGS-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
- 241000700159 Rattus Species 0.000 description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- -1 alkyl isothiocyanates Chemical class 0.000 description 5
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229960003151 mercaptamine Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 230000001078 anti-cholinergic effect Effects 0.000 description 3
- 230000001262 anti-secretory effect Effects 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 150000003222 pyridines Chemical class 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VHBFEIBMZHEWSX-UHFFFAOYSA-N 2-isothiocyanatopropane Chemical compound CC(C)N=C=S VHBFEIBMZHEWSX-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- MSSJBRXYLYSRLI-UHFFFAOYSA-N 1-methyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine Chemical compound C1NCCC2=C1N=CN2C MSSJBRXYLYSRLI-UHFFFAOYSA-N 0.000 description 1
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- GZPMJRJNFARLIB-UHFFFAOYSA-N 3,4-diethyl-n-propan-2-yl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound CCC1N(C(=S)NC(C)C)CCC2=C1N(CC)C=N2 GZPMJRJNFARLIB-UHFFFAOYSA-N 0.000 description 1
- CKJIMCWELNMHRJ-UHFFFAOYSA-N 4-ethyl-3-methyl-n-propan-2-yl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound CCC1N(C(=S)NC(C)C)CCC2=C1N(C)C=N2 CKJIMCWELNMHRJ-UHFFFAOYSA-N 0.000 description 1
- RVRGWEYCNVKOQT-UHFFFAOYSA-N 4-ethyl-4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine Chemical compound CCC1NCCC2=C1N=CN2 RVRGWEYCNVKOQT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- FPBPLBWLMYGIQR-UHFFFAOYSA-N Metiamide Chemical compound CNC(=S)NCCSCC=1N=CNC=1C FPBPLBWLMYGIQR-UHFFFAOYSA-N 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- WLASFIJASFULQX-UHFFFAOYSA-N benzyl 3,4-diethyl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carboxylate Chemical compound C1CC=2N=CN(CC)C=2C(CC)N1C(=O)OCC1=CC=CC=C1 WLASFIJASFULQX-UHFFFAOYSA-N 0.000 description 1
- HOUMLKBUHCLYNX-UHFFFAOYSA-N benzyl 4-ethyl-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-5-carboxylate;hydrochloride Chemical compound Cl.C1CC=2NC=NC=2C(CC)N1C(=O)OCC1=CC=CC=C1 HOUMLKBUHCLYNX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- HIYSJIVKGLMUFH-UHFFFAOYSA-N n,1-dimethyl-6,7-dihydro-4h-imidazo[4,5-c]pyridine-5-carbothioamide Chemical compound C1N(C(=S)NC)CCC2=C1N=CN2C HIYSJIVKGLMUFH-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT26562/78A IT1098015B (it) | 1978-08-07 | 1978-08-07 | Nuovi 4,5,6,7,-tetraidroimidazo-aperta par.quadrata 4,5-c chiusa par.quadrata-piridin-derivati |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7811761L SE7811761L (sv) | 1980-02-08 |
| SE438150B true SE438150B (sv) | 1985-04-01 |
Family
ID=11219781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7811761A SE438150B (sv) | 1978-08-07 | 1978-11-14 | 4,5,6,7-tetrahydroimidazo(4,5-c)pyridinderivat och forfarande for deras framstellning |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4223146A (de) |
| JP (1) | JPS5810387B2 (de) |
| AT (1) | AT357533B (de) |
| AU (1) | AU520102B2 (de) |
| BE (1) | BE871985A (de) |
| CA (1) | CA1113468A (de) |
| CH (1) | CH636875A5 (de) |
| DE (1) | DE2849572C2 (de) |
| DK (1) | DK146159C (de) |
| FR (1) | FR2433022A1 (de) |
| GB (1) | GB2028798B (de) |
| IT (1) | IT1098015B (de) |
| NL (1) | NL181657C (de) |
| SE (1) | SE438150B (de) |
| SU (1) | SU791241A3 (de) |
| ZA (1) | ZA786388B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4812462A (en) * | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
| CA2737527C (en) * | 2008-09-16 | 2015-12-29 | Proximagen Limited | 4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds useful as inhibitors of ssao activity |
| GB201507031D0 (en) | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| GB201507036D0 (en) | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141899A (en) * | 1976-01-07 | 1979-02-27 | Societa' Farmaceutici Italia S.P.A. | 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives |
| NL7614577A (nl) * | 1976-01-07 | 1977-07-11 | Farmaceutici Italia | Werkwijze voor het bereiden van nieuwe 4,5,6,7- -tetrahydroimidazo (4,5-c)-pyridinederivaten. |
-
1978
- 1978-08-07 IT IT26562/78A patent/IT1098015B/it active
- 1978-11-09 NL NLAANVRAGE7811125,A patent/NL181657C/xx not_active IP Right Cessation
- 1978-11-10 CA CA316,132A patent/CA1113468A/en not_active Expired
- 1978-11-10 CH CH1159678A patent/CH636875A5/de not_active IP Right Cessation
- 1978-11-10 AU AU41490/78A patent/AU520102B2/en not_active Expired
- 1978-11-13 GB GB7844281A patent/GB2028798B/en not_active Expired
- 1978-11-13 FR FR7831960A patent/FR2433022A1/fr active Granted
- 1978-11-13 DK DK502678A patent/DK146159C/da not_active IP Right Cessation
- 1978-11-13 US US05/959,506 patent/US4223146A/en not_active Expired - Lifetime
- 1978-11-13 AT AT811778A patent/AT357533B/de not_active IP Right Cessation
- 1978-11-14 BE BE191705A patent/BE871985A/xx not_active IP Right Cessation
- 1978-11-14 SE SE7811761A patent/SE438150B/sv not_active IP Right Cessation
- 1978-11-14 JP JP53139477A patent/JPS5810387B2/ja not_active Expired
- 1978-11-14 ZA ZA00786388A patent/ZA786388B/xx unknown
- 1978-11-15 SU SU782685600A patent/SU791241A3/ru active
- 1978-11-15 DE DE2849572A patent/DE2849572C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK146159C (da) | 1983-12-05 |
| BE871985A (fr) | 1979-03-01 |
| NL181657C (nl) | 1987-10-01 |
| GB2028798B (en) | 1982-08-11 |
| JPS5524158A (en) | 1980-02-21 |
| CA1113468A (en) | 1981-12-01 |
| AU4149078A (en) | 1980-02-14 |
| GB2028798A (en) | 1980-03-12 |
| DE2849572A1 (de) | 1980-02-21 |
| JPS5810387B2 (ja) | 1983-02-25 |
| DK502678A (da) | 1980-02-08 |
| DK146159B (da) | 1983-07-11 |
| ATA811778A (de) | 1979-12-15 |
| CH636875A5 (de) | 1983-06-30 |
| AT357533B (de) | 1980-07-10 |
| FR2433022B1 (de) | 1981-06-12 |
| US4223146A (en) | 1980-09-16 |
| DE2849572C2 (de) | 1986-06-26 |
| AU520102B2 (en) | 1982-01-14 |
| SE7811761L (sv) | 1980-02-08 |
| ZA786388B (en) | 1979-10-31 |
| SU791241A3 (ru) | 1980-12-23 |
| IT7826562A0 (it) | 1978-08-07 |
| FR2433022A1 (fr) | 1980-03-07 |
| IT1098015B (it) | 1985-08-31 |
| NL181657B (nl) | 1987-05-04 |
| NL7811125A (nl) | 1980-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2024521C1 (ru) | Производные дифенилметилимидазола или их фармацевтически приемлемые соли | |
| HU187478B (en) | Process for preparing new imidazolyl-phenyl-amidines and pharmaceutical compositions containing thereof | |
| JP2707936B2 (ja) | β−オキソ−β−ベンゼンプロパンチオアミド誘導体 | |
| SE438150B (sv) | 4,5,6,7-tetrahydroimidazo(4,5-c)pyridinderivat och forfarande for deras framstellning | |
| Shi et al. | Efficient one‐pot synthesis of s‐triazolo [3, 4‐b]‐[1, 3, 5] thiadiazines containing a chiral side chain by double mannich type reaction | |
| DD204924A5 (de) | Verfahren zur herstellung n-substituierter 2-pyridylindole | |
| EP0191045B1 (de) | Anwendung von 4-(isoxazolyl)-thiazol-2-oxamidsäurederivaten | |
| FI57586B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbart 1-(2-(beta-naftyloxi)-etyl)-3-metyl-pyrazolon-(5) | |
| US4560696A (en) | Analgesic, antipyretic or anti-inflammatory imidazole compounds | |
| HUP0104278A2 (hu) | Új eljárás 7-azaindolil-3-karbonsav és 7-azaindol előállítására, valamint intermedierjeik | |
| EP0163842A1 (de) | Tricyclische Imidazolderivate | |
| JPH0142952B2 (de) | ||
| NO883339L (no) | Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser. | |
| US4213986A (en) | Novel derivatives of imidazole and pharmaceutical compositions containing them and method of use | |
| IE44184B1 (en) | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| CS213395B2 (en) | Method of making the derivatives of 1-phenyl-2,5-cyclohexadien-1-ethylamine | |
| US5453529A (en) | Nitroimino compound as intermediate for insecticides and pharmaceuticals | |
| EP0090275A2 (de) | Isoxazole (5,4-b) Pyridine | |
| CS208746B2 (en) | Method of making the 3,6-disubstituted-1,2,4-triazin 5-ons | |
| US4737511A (en) | Cardiotonic imidazolylphenylpyrrol-2-ones | |
| US4879404A (en) | Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same | |
| US4355166A (en) | Quinuclidinic ester and derivatives of phenoxycarboxylic acids | |
| EP0008150B1 (de) | 2,6-Dichlorphenyl-substituierte Amino-imidazol-Derivate, Verfahren zur Herstellung dieser Derivate und diese Derivate enthaltende pharmazeutische Zusammensetzungen | |
| CA1247623A (en) | Derivatives of 2-(2-thienyl)-imidazo-¬4,5-b|- pyridines and their pharmaceutically acceptable salts and a process for the preparation thereof | |
| HU191597B (en) | Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7811761-1 Effective date: 19891120 Format of ref document f/p: F |